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Background: Paracrine signaling of the hepatocyte growth factor (HGF) cytokine plays an important role in survival
and invasion ability of placental trophoblasts. However, the intracellular factors and biological pathways underlying
these responses remain unclear.
Methods: This study investigated whether HGF affected the expression of homeobox gene HLX1, which is
principally expressed in reproductive tissues and in some immune cells, and evaluated the implications of such in
the HGF-induced human trophoblast cell line HTR-8/SVneo.
Results: HGF was found to up-regulate both HLX1 mRNA and protein levels. Transient transfection of small
interfering RNA (siRNA) targeting HLX1 abrogated its induction by HGF. Functionally, HLX1 siRNA not only reduced
the growth and invasion capacities of HTR-8/SVneo cells at the basal level, but also inhibited these responses
induced by HGF treatment.
Conclusions: HLX1 is an essential downstream signaling component of HGF that leads to growth and invasiveness
of trophoblast cells.
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Trophoblasts are specialized placental cells that facilitate
embryo implantation and subsequently differentiate to
form the placenta. Both processes depend extensively on
complex and dynamic molecular crosstalk between fetal
and maternal tissues. Upon blastocyst implantation, tro-
phoblasts begin to differentiate into two distinct subpo-
pulations, namely the villous trophoblasts (VTs) and
extravillous trophoblasts (EVTs). The VTs function
mainly to exchange gas and nutrients between the
mother and the fetus, while the EVTs invade into the
maternal uterus and establish feto-placental vasculature
[1]. Mounting evidence has implicated various cytokines
and growth factors in regulating the growth and invasion
ability of EVTs; these include hepatocyte growth factor
(HGF), epidermal growth factor (EGF), transforming* Correspondence: qlhaiyingliu@yahoo.com.cn
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reproduction in any medium, provided the orgrowth factor beta (TGFβ), insulin-like growth factor II
(IGF-II) and interleukin β (IL-β) [1]. Among these fac-
tors, HGF is a particularly potent paracrine mitogen,
motogen and morphogen, known to act on multiple cell
types during various developmental and regenerative
processes, including embryonic organogenesis, adult tis-
sue regeneration after injury and wound healing [2].
HGF binding to the cell-surface receptor Met tyrosine
kinase triggers a multi-component signal transduction
pathway that leads to dynamic biological responses.
Homozygous HGF gene knockout in transgenic mice
resulted in severely impaired placental development and
markedly reduced trophoblast numbers; ultimately, the
embryos produced in HGF−/− mothers suffered prenatal
death [3,4]. Intriguingly, a similar placental failure was
observed in mice containing homozygous mutants of the
c-met gene, which supported the hypothesized role of
HGF/c-met signaling in physiological placental develop-
ment [5].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of HGF in mature placenta is approximately 100- to
200-fold higher than that obtained from human
plasma, implying its significant role in placental func-
tions [6]. During pregnancy, placental HGF expression
is restricted to the villous core mesenchymal cells, and
c-met is mainly expressed on the surfaces of tropho-
blasts and endothelial cells [7,8]. These distinctive ex-
pression patterns imply that HGF may serve as a
paracrine mediator of trophoblasts and endothelial cells
to control placental development and growth. In agree-
ment with this idea, low maternal HGF levels in
humans have been correlated with pregnancies yielding
infants small for their gestational age [9]. In vitro and
in vivo molecular studies have revealed that HGF sti-
mulates growth and invasion ability of trophoblasts
[7,10-13], yet the underlying factors involved in the sig-
naling mechanisms remain to be identified.
Homeobox gene transcription factors are a family of
homeodomain-containing proteins that regulate cellular
differentiation and organ development. HLX1 is a
homeobox family member that is mainly expressed in
VTs and EVTs of early-pregnancy placenta and in re-
sidual EVTs of full-term placenta [14]. HLX1 expression
was found to be down-regulated in fetal growth-
restricted (FGR) human placenta, as compared to that in
normal growth placenta [15]. This finding suggested that
unbalanced HLX1 expression may contribute to the
pathogeneses of placental and trophoblastic diseases.
The additional finding that the down-regulated HLX1 in
FGR placenta was accompanied by reduced HGF expres-
sion [15] prompted us to examine the potential crosstalk
between these two molecules. In this study, we used the
EVT cell line HTR-8/SVneo to investigate HLX1 expres-
sion in response to HGF and small interfering RNA
(siRNA) gene targeting to determine whether HGF-
mediated HLX1 contributes to the biological processes
induced by HGF.Methods
Cell culture, HGF treatment and siRNA transfection
The human EVT cell line HTR-8/SVneo was generously
provided by Dr. Charles H. Graham (Department of Anat-
omy & Cell Biology, Queen’s University at Kingston,
Canada). Cells were cultured in RPMI-1640 medium
(Hyclone, China) supplemented with 10% heat-inactivated
fetal bovine serum (FBS; Sijiqing Biotec Co., China) in a
sterile incubator at 37°C with 95% humidity and 5% CO2.
For HGF treatment, cells were grown to log phase,
released from the culture dish by trypsinization (0.25%
trypsin; Sigma, USA), and seeded into 6-well plates at
2 × 105 cells/well. Twenty-four hours later, cells were
starved in RPMI-1640 medium containing 0.5% FBS for12 h and then treated with HGF (PeproTech, USA) at
different concentrations for a further 48 h.
A DY-547-labeled control siRNA duplex (sense-strand
sequence: 5'- UAGCGACUAAACACAUCAAUU-3') that
targets no known human genes, and an siRNA pool
containing four siRNA duplexes specifically targeting
human HLX1 sequences were purchased from Dharma-
con (USA). The sense-strand sequences for the four
HLX1 siRNA duplexes were as follows: HLX1-si1
5'-GAAAUUCAGUUCAGCAUCA-3'; HLX1-si2 5'-G
GUUUGAGAUUCAGAAGUA-3'; HLX1-si3 5'-GAU
CUCACUUCCCUGCUAA-3'; and HLX1-si4 5'-GGA
CGCGAGUGGUUCCGAA-3'. siRNA was transfected
into HTR-8/SVneo cells using DharmaFECT1 reagent
(Dharmacon) following the manufacturer’s instructions.
Reverse transcription followed by quantitative real-;time
(q)PCR
Total RNA was extracted from cells using Trizol reagent
(Invitrogen, USA), according to the manufacturer’s proto-
col. Following quantification by UV spectrophotometer,
2 μg of total RNA was reverse transcribed into cDNA by
using a commercially-available reverse transcription kit
(Fermentas, Lithuania). The cDNA was then used as a
template for subsequent qPCR analysis with SYBRW Pre-
mix Ex TaqTM and the following primers (TaKaRa, Japan):
β-actin (internal control, amplicon size of 188 bp): up-
stream 5'-TGGCACCCAGCACAATGAA-30 and down-
stream 50-CTAAGTCATAGTCCGCCTAGAAGCA-30;
HLX1 (amplicon size of 175 bp): upstream 50-
CAGTTCAGCATCAGTTCCAAGACAC −30 and down-
stream 50-TCCGGCTTGGTCACGTACTTC-30. Thermal
cycling conditions for amplification were: one cycle of
95°C for 20 sec, followed by 45 cycles of 95°C for 5 sec,
60°C for 30 sec and 72°C for 10 sec. The relative gene
expression was calculated using the 2-ΔΔCt method, as
previously described [16].
Western immunoblot
Cells were lysed in sodium dodecyl sulfate (SDS) lysis
buffer (Beyotime, China) and the total protein concen-
tration was determined using the BCA protein assay kit
(Beyotime), following the manufacturer’s instructions. An
80 μg aliquot of total protein from each sample was
separated by 10% SDS-polyacrylamide gel electrophoresis
(PAGE) and electrotransferred to a nitrocellulose mem-
brane. After blocking with 5% skim milk at room
temperature for 3 h, the membrane was incubated with
one of the following primary antibodies at 4°C overnight:
rabbit anti-HLX1 (0.25 μg/μL; Abcam, USA) or mouse
anti-β-actin (0.1 μg/μL; Santa Cruz Biotech., USA). After
washing, the membrane was incubated with horseradish
peroxidase-conjugated anti-rabbit secondary antibody
(1:1000; Zymed, USA) at room temperature for 90 min
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minescent substrate and detected on a Kodak gel im-
aging station. Immunoreactive signals were quantified
using JEDA imaging and analysis software (version 3.3;
JEDA Science-Tech., China), and presented as the inten-
sity ratio of HLX1 signal to β-actin signal.
Flow cytometry
At 24 h after transfection of HTR-8/SVneo cells with
different concentrations of DY-547-tagged control
siRNA, cells were trypsinized, resuspended in ice-cold
sterile phosphate buffered saline (PBS), and analyzed by
flow cytometry. The percentage of DY-547-positive cells
was used as an indicator of transfection efficiency.
Cell viability by MTT assay
HTR-8/SVneo cells at log phase were seeded into 96-well
plates at 5 × 103 cells/well. After overnight incubation,
cells were transfected with either control or HLX1 siRNA
(time 0; five replicates for each condition). At 0, 24, 48,
72 and 96 h post-transfection, the cell viability was deter-
mined using MTT reagent (Gibco, USA) and reading ab-
sorbance (A) at 490 nm. The growth inhibition was
calculated as [(1-AExperiment/ABlank well) × 100%].
Gelatin zymography of matrix metalloproteinases (MMP)2
and MMP9
Confluent cultures of trophoblast cells were starved for
24 h in RPMI-1640 medium supplemented with 0.5% FBS.
Following starvation, the cells were stimulated with
20 ng/mL HGF in serum-free media for a further 24 h.
The mock-stimulated control cells were treated with only
serum-free medium, without HGF added. For experiments
involving HLX1 down-regulation with HGF stimulation,
cells were transfected with siRNA prior to serum starva-
tion and HGF stimulation. Following the treatment, condi-
tioned medium was harvested from the cells and a 10 μL
aliquot was mixed with an equal volume of 2× Laemmli
sample buffer and separated on an 8% SDS-PAGE gel con-
taining 0.1% gelatin. After electrophoresis, gels were
soaked and washed twice in 2.5% Triton X-100 for 45 min
each at 37°C and then incubated in a buffer containing
50 mM Tris buffer, pH 7.5, 200 nM NaCl, 5 mM CaCl2
1 μM ZnCl2, and 0.2% Brij 35 at 37°C overnight. After
12 h, the gels were stained for 4 h with 0.25% Coomassie
Brilliant Blue G-250 in a solution of 10% acetic acid and
45% methanol, and then destained for 30 minutes in the
same solution without Coomassie. The Coomassie-stained
gel was imaged using the Kodak gel imaging station and
analyzed by JEDA imaging and analysis software. Condi-
tioned medium from human fibrosarcoma cells HT1080
was collected for use as the positive control for MMP2
and MMP9 activity.Transwell invasion assay
The high concentration Matrigel matrix (BD Biosciences,
USA) was thawed at 4°C, diluted 1:3 in RPMI-1640
medium, coated on the upperside of a transwell insert
(8 μm pore size; Corning, USA) at 100 μL/insert and
incubated at 37°C for 30 min. Meanwhile, cells were
resuspended in serum-free RPMI-1640 medium at
1 × 105 cells/mL and 400 μL aliquots were deposited on
the top of the transwell insert. To the bottom well, 1200
μL of RPMI-1640 medium with 20% FBS was added. The
invasion assay was allowed to proceed at 37°C for 12 h.
After the invasion period, the cells remaining on top
were gently removed by a cotton swab, and those that
had transversed to the bottom side of the insert were
fixed in methanol and stained with hematoxylin. The in-
sert membrane was then cut out and mounted onto glass
slides with the bottom side facing upward. The invasive
cells were imaged under a light microscope (IX81; Olym-
pus, Japan) at 400 ×magnification. Five random fields
were imaged for each membrane and the cell numbers
detected in each were averaged.
Statistical analysis
Quantitative data are presented as mean ± standard devi-
ation (SD) for at least three independent experiments.
Differences between groups were evaluated by using
one-way analysis of variance (ANOVA). All statistical
analyses were carried out with SPSS software (version
11.0; SPSS Institute, USA). A P-value of <0.05 was con-
sidered statistically significant.
Results
HGF up-regulates the expression of HLX1 in HTR-8/SVneo
cells
In response to increasing concentrations of HGF, the
steady-state mRNA level of HLX1 in HTR-8/SVneo cells
showed a dose-dependent increase (Figure 1A), and
significant difference was achieved with as little as
10 ng/mL HGF (P < 0.01). At 100 ng/mL HGF, the
mRNA level of HLX1 increased to almost five-fold more
than that of the endogenous level in HTR-8/SVneo cells.
For subsequent experiments, we chose the intermediate
dose of HGF (20 ng/mL) that showed the most robust
dose response among all HGF concentrations tested.
Similar changes were also observed at the protein level
of HLX1 (Figure 1B). When HTR-8/SVneo cells were
treated with 20 ng/mL HGF, the protein level of HLX1
was approximately 2.6-fold higher than that in cells
without HGF treatment (P < 0.01).
Targeting HLX1 with siRNA abrogates basal expression
and induction by HGF
Given the apparent HGF-inducible nature of HLX1, we
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Figure 1 HGF up-regulates the expression of HLX1 in
HTR-8/SVneo cells. (A) HTR-8/SVneo cells were treated with the
indicated concentrations of HGF for 48 h. The steady-state mRNA
level of HLX1 was examined by qPCR and normalized to a β-actin
internal control. The ratio of HLX1/β-actin mRNA in cells treated
with 0 ng/mL HGF was arbitrarily defined as 1. Data are presented as
mean± SD for three independent experiments. *P< 0.01, vs. 0 ng/mL
HGF. (B) HTR-8/SVneo cells were treated with 0 ng/mL (−) or 20
ng/mL (+) HGF for 48 h. The protein level of HLX1 was determined
by Western immunoblot and normalized to β-actin internal control.
A representative gel image is presented in the upper panel and
quantification of HLX1 to β-actin signal ratio from three
independent experiments is shown in the lower panel. The ratio in
–HGF cells was arbitrarily defined as 1. *P< 0.01, vs. 0 ng/mL HGF.
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plied by knocking down the expression of HLX1 with
siRNA-mediated gene targeting. We first examined the ef-
ficiency of siRNA transfection by using the fluorescent
probe DY-547-tagged non-targeting control siRNA
(siCtrl). By transfecting 10, 50 and 100 nM siRNA, we
found that the 100 nM concentration produced the high-
est transfection efficiency (86.3 ± 2.6%; Figure 2A). There-
fore, this dosage was used for all subsequent experiments.At 48 h after siRNA transfection, we examined the
mRNA and protein levels of HLX1 by qPCR and
Western blot, respectively. As shown in Figure 2B and
2C, transfection with the HLX1 siRNA pool (siHLX1)
significantly reduced HLX1 expression on both mRNA
and protein levels, as compared to the levels detected in
siCtrl-transfected or non-transfected (NT) HTR-8/
SVneo cells (P < 0.01). In addition to down-regulating
endogenous HLX1, siHLX1 also inhibited its HGF-
induced expression levels in both mRNA and protein
(Figure 2D and 2E). HGF treatment of siCtrl cells led to
an approximate 2.7-fold increase in HLX1 mRNA and
2.8-fold increase in HLX1 protein. In contrast, siHLX1
transfected cells presented reduced HLX1 mRNA (by
55%) and protein (by 52%), even in the presence of HGF
(P < 0.01) suggesting that HLX1 siRNA has a more dom-
inant effect over HGF in regulating HLX1 expression.
These three treatments provide us a model where the
intracellular HLX1 levels vary from each other, therefore
allowing us to further observe the significance of HLX1
in cellular behaviors as detailed below.
Targeting HLX1 inhibits basal and HGF-induced cell
growth
HGF is an important mitogen and motogen for tropho-
blasts, essentially regulating their proliferation, apoptosis
and migration/invasion capabilities [3,17,18]. To evaluate
the significance of HLX1 in HGF-mediated biological
processes, we first examined HGF-induced growth of
cells transfected with either siCtrl or siHLX1 by using
the MTT assay (Figure 3A). The same number of cells
were transfected at time 0. Under basal conditions,
namely without HGF treatment, both NT and siCtrl-
transfected HTR-8/SVneo cells grew steadily within the
96 h post-transfection observation period. However, this
growth was dramatically reduced in the siHLX1-
transfected cells, and a significant difference was found
to have occurred as early as 24 h after siRNA transfec-
tion. The largest difference was observed at 72 h after
transfection, with growth inhibition of 58.1 ± 4.4%
(P < 0.01).
In response to HGF treatment, siCtrl cells grew signifi-
cantly slower than siCtrl +HGF cells, but faster than
siHLX1 cells, over the 96 h observation period following
siRNA transfection (P < 0.01; Figure 3B). The growth
observed for siHLX1 +HGF cells, however, was not dra-
matically different from siCtrl cells at 24 and 48 h post-
transfection, but was significantly reduced at 72 and
96 h post-transfection (P < 0.01).
Targeting HLX1 reduces HGF-induced cell invasiveness
and production of MMP2
Next, the effects of knocking down HLX1 were deter-











































































Figure 2 Targeting HLX1 with siRNA abrogates its basal expression and induction by HGF. (A) DY-547-labeled control siRNA (siCtrl) was
transfected into HTR-8/SVneo cells for 24 h. The transfection efficiency, as determined by flow cytometry, is presented. Black line, non-
transfected (NT) cells; gray line, siCtrl cells. (B) The steady-state mRNA level of HLX1 in indicated HTR-8/SVneo cells was examined by
qPCR and calculated as the ratio of HLX1 to β-actin. (C) The protein level of HLX1 in indicated HTR-8/SVneo cells was examined by
Western immunoblot. A representative gel image is presented on the left and quantifications of HLX1 to β-actin signal ratio on the
right.(D) HTR-8/SVneo cells were transfected with either siCtrl or siHLX1 and treated with or without 20 ng/mL HGF. The steady-state
mRNA level of HLX1 was examined by qPCR and calculated as the ratio of HLX1 to β-actin. (E) HTR-8/SVneo cells were treated as in
(D) and the protein level of HLX1 was examined by Western immunoblot. A representative gel image is presented on the left and
quantifications of HLX1 to β-actin signal ratio on the right. Quantitative data are presented as mean ± SD for three independent
experiments. For (B) and (C), the relative ratio in NT cells arbitrarily defined as 1. *P < 0.01, vs. NT and siCtrl cells. For (D) and (E), the
relative ratio in siCtrl-transfected cells arbitrarily defined as 1. *P < 0.01, vs. siCtrl cells.
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matrigel, we found that siHLX1 transfection not only
reduced the basal invasiveness of HTR-8/SVneo cells
(vs. NT or siCtrl-transfected cells, P < 0.01; Figure 4A),
but also significantly inhibited the HGF-induced inva-
sion properties (vs. compared to siCtrl-transfected cells
or siCtrl-transfected cells treated with HGF, P < 0.01;
Figure 4B).
To understand the regulatory mechanism underlying
HLX1 associated HGF-induced cell invasiveness, we fo-
cused on two matrix metalloproteinase molecules,
MMP2 and MMP9, that are characterized as down-
stream targets for HGF and important regulators of cell
migration/invasion [19]. By gelatin zymography analysis,
we found that the MMP2 activity in the conditioned
medium was significantly enhanced upon HGF treat-
ment, but not affected by siCtrl transfection (siCtrl vs.
siCtrl +HGF or NT vs. NT+HGF samples, P < 0.01;
siCtrl vs. NT or siCtrl +HGF vs. NT+HGF samples,
P > 0.05; Figure 4C). Transfection of siHLX1, however,
significantly reduced the MMP2 activity in the condi-
tioned medium (vs. all other samples, P < 0.01). The
MMP9 activity was very low in the conditioned medium,
as compared with that in the conditioned medium from
HT1080 cells, and no significant variations were found
between HTR-8/SVneo cells treated with HGF or trans-
fected with siHLX1.Discussion
In this study, we identified HLX1 as a downstream tar-
get for HGF signaling in the extravillous trophoblast cell
line HTR-8/SVneo. Our analysis provided experimental
evidence that HLX1 is essential for the in vitro growth
and invasion properties of HTR-8/SVneo cells under
regular culture conditions or in response to HGF
treatment.
HTR-8/SVneo cells were originally derived from first-
trimester villous explants and immortalized by transfec-
tion with the pSV3neo vector containing the early region
of SV40 encoding the simian virus 40 large T antigen
[20]. Despite being immortalized, these cells retain re-
markably similar gene and protein expression profiles as
the parental mortal HTR-8 cells. The characteristic cell-
type molecules are cytokeratins 18 and 8, human placen-
tal lactogen (hPL), human chorionic gonadotropin
(hCG), human leukocyte antigen G (HLA-G), and type
IV collagenase. Furthermore, like the source HTR-8
cells, HTR-8/SVneo cells lack the capability to grow in
soft agar and produce no tumors following subcutaneous
injection into nude mice [20,21]. These features make
HTR-8/SVneo cells an ideal in vitro model for studying
the biology of normal trophoblasts.
The HTR-8/SVneo cells in our study responded to
HGF treatment with increased cell growth and enhanced
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Figure 3 Targeted silencing of HLX1 inhibits basal and HGF-
induced cell growth. (A) HTR-8/SVneo cells were either not
transfected (NT), or transfected with siCtrl or siHLX and cell growth
at 0, 24, 48, 72 and 94 h after transfection was determined by MTT
assay. (B) HTR-8/SVneo cells were transfected with either siCtrl or
siHLX1 at time 0, and treated with or without 20 ng/mL HGF. Cell
growth at 0, 24, 48, 72 and 94 h after transfection was determined
by MTT assay with the absorbance of viable cells read at 490 nm
(OD490). All quantitative data are presented as mean± SD for three
independent experiments. *P< 0.01, as compared to NT cells or
siCtrl-transfected cells (in A), and to siCtrl + HGF or siHLX1 cells
(in B). #P< 0.01, as compared to siHLX1+HGF cells (in B).
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[6,18,22]. The invasion capacity of EVTs has been the
focus of extensive studies to date since decreased
trophoblast invasion is a characteristic feature of pree-
clampsia, a dangerous complication of pregnancy that
results in significant maternal and fetal morbidity and
mortality. Lala et al. reported that HGF enhances the
in vitro invasiveness of trophoblasts by approximately 4-
fold [23]. Likewise, Dokras et al. demonstrated that ex-
pression of recombinant (r)HGF significantly increased
the invasive activity of cytotrophoblasts isolated from all
three trimesters [22]. Finally, Kauma et al. observed an
HGF dose-dependent increase in the invasiveness of
ED27 trophoblast cells across type I collagen [18].
Concomitant with the increased growth and invasion
in response to HGF, we also observed a dose-dependentup-regulation of HLX1, suggesting that HLX1 is a down-
stream target of HGF. In hematopoietic progenitor cells,
HLX1 is an important regulator of cell proliferation, dif-
ferentiation and migration in response to growth factors
or cytokines [24,25]. The common process of cell growth
and migration/invasion that are regulated by both HGF
and HLX1 prompted us to test whether HLX1 was able
to mediate the growth and invasion responses to HGF in
trophoblasts. By using siRNA-mediated gene targeting,
we successfully knocked down endogenous HLX1, and
found that HGF-induced HLX1 was also abrogated. Fol-
lowing siRNA transfection, we found that knocking
down HLX1 not only significantly reduced cell growth
but also inhibited the invasiveness of HTR-8/SVneo cells
in response to HGF, suggesting that HLX1 is an essential
mediator for HGF-induced trophoblast growth and inva-
sion. In addition, these reductions also occurred in the
absence of HGF treatment, implying that the endogen-
ous level of HLX1, although it can be further increased
by HGF, is necessary to maintain the basal growth and
invasiveness of HTR-8/SVneo cells.
To gain an even further understanding of the mechan-
isms underlying HLX1-regulated cell invasion, we exam-
ined MMP2 and MMP9. The matrix metalloproteinases
are critical mediators of extracellular matrix (ECM) deg-
radation. Several studies have identified the significant
involvement of both MMP2 and MMP9 in trophoblast
invasion of the uterus [26,27]. In our study, we found
that HGF stimulated the production of MMP2 and that
this response was dramatically reduced upon knocking
down HLX1. The activity of MMP9, on the other hand,
was not significantly altered by either HGF treatment or
HLX1 knock-down. This result indicated that MMP2,
but not MMP9, is likely a particular MMP that contri-
butes to the HGF- and HLX1-induced trophoblast inva-
sion property. It is worthwhile to further study whether
HLX1 directly acts on the MMP2 promoter or function
indirectly through some other transcription factor.
Recently, Rajaraman et al. published their work on the
significance of HLX1 in mediating HGF-induced migra-
tion of human trophoblasts [28]. Using two different
human EVT cell lines, SGHPL-4 and HTR-8/SVneo, this
group showed that HLX1 is induced by HGF, consistent
with our findings. Interestingly, only the migration assay,
but not the invasion assay, showed functional signifi-
cance of HLX1. At this point, it is unclear what has
caused the discordant observations in HLX1-mediated
invasion between their study and ours. However, some
important differences in study design exist: 1) Rajaraman
et al. did not investigate the functional significance of
endogenous HLX1, without HGF treatment, in cell inva-
sion; and 2) the HGF dose used was different, albeit not
to a great extent (Rajaraman et al.: 10 ng/mL and our





























Figure 4 Targeting HLX1 reduces the cell invasion and the production of MMP2 in response to HGF. (A) HTR-8/SVneo cells were either
not transfected (NT), or transfected with siCtrl or siHLX. The invasion of transfected cells across matrigel was determined by a transwell assay.
Images of representative invasive cells are shown on the left, and quantifications are shown on the right. (B) HTR-8/SVneo cells were transfected
with either siCtrl or siHLX1 and treated with or without 20 ng/mL HGF. The invasion of transfected cells across matrigel was determined by a
transwell assay. Images of representative invasive cells are shown on the left, and quantifications are shown on the right. All quantitative data are
presented as mean± SD for three independent experiments. *P< 0.01, as compared to the other two groups. (C) HTR-8/SVneo cells were treated
as indicated. The MMP2 and MMP9 levels in the conditioned medium from the cells were measured by gelatin zymography; conditioned
medium collected from HT1080 cells were used as a positive control (PC).
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future analysis to more trophoblast cell lines, and even
animal models.
Conclusions
In summary, we have shown that HLX1 is a downstream
mediator of HGF-induced growth and invasion proper-
ties of the HTR-8/SVneo trophoblast cells. Given that
both HGF and HLX1 are significantly associated with
normal placental development and pathogenesis of
placenta-related diseases, understanding the crosstalk
between these two molecules may help to develop thera-
peutic approaches that will benefit normal pregnancy
and treat pathological situations.
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